The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Mezavant XL 1200 mg gastro-resistant, prolonged release tablets

Originalis B.V.PPA2306/023/001

Main Information

Trade NameMezavant XL 1200 mg gastro-resistant, prolonged release tablets
Active SubstancesMesalazine
Dosage FormProlonged-release tablet
Licence HolderOriginalis B.V.
Licence NumberPPA2306/023/001

Group Information

ATC CodeA07EC Aminosalicylic acid and similar agents
A07EC02 mesalazine


License statusAuthorised
Licence Issued06/05/2022
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back